Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.

[1]  Ignacio I. Wistuba,et al.  The Role of PKR/eIF2α Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer , 2011, PloS one.

[2]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[3]  Hui Zhou,et al.  Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78) , 2011, The Journal of Biological Chemistry.

[4]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[5]  A. Ross,et al.  Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. , 2011, The Journal of clinical investigation.

[6]  Amy S. Lee,et al.  The critical role of GRP78 in physiologic and pathologic stress. , 2011, Current opinion in cell biology.

[7]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[8]  G S Stein,et al.  Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease , 2011, British Journal of Cancer.

[9]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[10]  Joydeep Mukherjee,et al.  Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme , 2011, The Journal of experimental medicine.

[11]  J. Edwards,et al.  GRP78 up‐regulation is associated with androgen receptor status, Hsp70–Hsp90 client proteins and castrate‐resistant prostate cancer , 2011, The Journal of pathology.

[12]  Damien Kee,et al.  Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. , 2010, Cancer cell.

[13]  Cole M. Haynes,et al.  The mitochondrial UPR – protecting organelle protein homeostasis , 2010, Journal of Cell Science.

[14]  M. Mayer.  Gymnastics of molecular chaperones. , 2010, Molecular cell.

[15]  G. Giaccone,et al.  Targeting the dynamic HSP90 complex in cancer , 2010, Nature Reviews Cancer.

[16]  S. Lindquist,et al.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights , 2010, Nature Reviews Molecular Cell Biology.

[17]  C. Hetz,et al.  Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. , 2009, Molecular cell.

[18]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[19]  Michael R. Duchen,et al.  PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death , 2009, Molecular cell.

[20]  L. Neckers,et al.  Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. , 2009, The Journal of clinical investigation.

[21]  J. Downward,et al.  Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response , 2009, Cell Death and Differentiation.

[22]  L. Chin,et al.  Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. , 2009, Molecular cell.

[23]  A. Hezel,et al.  LKB1; linking cell structure and tumor suppression , 2008, Oncogene.

[24]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[25]  J. Reinstein,et al.  The ATPase Cycle of the Mitochondrial Hsp90 Analog Trap1* , 2008, Journal of Biological Chemistry.

[26]  A. Lane,et al.  Under normoxia, 2-deoxy-d-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation , 2007, Molecular Cancer Therapeutics.

[27]  J. Reinstein,et al.  A Grp on the Hsp90 mechanism. , 2007, Molecular cell.

[28]  D. Altieri,et al.  Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network , 2007, Cell.

[29]  J. Massagué,et al.  Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. , 2007, Nature chemical biology.

[30]  N. Hay,et al.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.

[31]  B. Viollet,et al.  5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.

[32]  Y. Ohta,et al.  Suppression of Apoptosis by Cyclophilin D via Stabilization of Hexokinase II Mitochondrial Binding in Cancer Cells* , 2006, Journal of Biological Chemistry.

[33]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[34]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[35]  C. Thompson,et al.  Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. , 2004, Molecular cell.

[36]  L. Hendershot,et al.  The role of the unfolded protein response in tumour development: friend or foe? , 2004, Nature Reviews Cancer.

[37]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[38]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[39]  Xiaohua Shen,et al.  The unfolded protein response in nutrient sensing and differentiation , 2002, Nature Reviews Molecular Cell Biology.

[40]  G. Dorn,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2022 .